DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Bhagirath VC, Eikelboom JW, Hirsh J. et al.
Apixaban-calibrated anti-FXa activity in relation to outcome events and clinical characteristics in patients with atrial fibrillation: results from the AVERROES trial.
TH Open 2017;
1 (02) e139-e145
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.